Dr. Jolene WONG
Clinical Associate Professor
Qualifications: MBBS, MMED, FRCS Ed (Gen Surg)
Email: jolene.wong.s.m@singhealth.com.sg
Brief Biography:
Dr Jolene Wong is a Consultant at the Department of Sarcoma, Peritoneal and Rare Tumors (SPRinT). She graduated from the National University of Singapore (NUS) Yong Loo Lin School of Medicine Singapore with consecutive Dean’s list awards in 2014 and subsequently completed her General Surgery specialist training at Singhealth in 2019. She is a fellow of the Royal College of Surgeons (Edinburgh) and holds a Master of Medicine (Surgery). Having completed 2 years of local subspecialty training in the treatment of sarcoma, peritoneal surface malignancy, and skin cancers at the Singapore General Hospital (SGH) and KK Women’s & Children Hospital; Dr Wong continued to pursue her interest in innovative and minimally invasive approaches in the treatment of peritoneal disease at Ghent University Hospital, Belgium where she focused on the conduct of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC).
As a health services researcher with an interest in population health, Dr Wong holds a Master of Public Health (MPH) from the Harvard TH Chan School and completed her research fellowship at the Centre of Surgery and Public Health, Brigham and Women Hospital, Boston in 2023. Leveraging on her training in patient reported outcomes, health economics, data science and health services delivery, Dr Wong hopes to improve the quality of care for seriously ill and palliative older adults in surgery. Since 2019, she has received 6 institutional and national grants, including the Duke-NUS Nurturing Clinician Scientist Award in 2021 and the National Medical Research Council (NMRC) Population Health New Investigator Award in 2023. She has co-authored more than 40 peer reviewed publications over the last 5 years. In the arena of innovative technologies, Dr Wong led and completed Singhealth’s 1st PIPAC trial which has the potential to effectively palliate symptoms and improve survival in patients with peritoneal disease.
A pioneer in palliative surgical care research in Singapore and in the region, Dr Wong established the country’s first palliative surgery and intervention workgroup in 2020, providing a multi-disciplinary platform to improve care in this vulnerable group. She is also the SGH in the Ministry of Health End of Life (EOL) value driven care initiative. Recognising the importance of increasing awareness in serious illness and palliative education, Dr Wong spearheaded the palliative education program for Singhealth’s surgeons and hopes to further such initiatives in the future. She also has strong collaborations with population health teams with ongoing initiatives aimed at the delivery of specialist surgical oncology care in the community for older adults with serious illness.
Dr Wong is also active and passionate about medical education and training and is a clinician faculty member of the Sing health General Surgery Residency Program me and a clinical tutor to students from NUS, Duke and NTU.